Public-private partnerships for public health

被引：84

作者：

Reich, MR ^{[1
]}

机构：

[1] Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA

来源：

NATURE MEDICINE | 2000年 / 6卷 / 06期

关键词：

D O I：

10.1038/76176

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Global health problems require global solutions, and public–private partnerships are increasingly called on to provide these solutions. But although such partnerships may be able to produce the desired outcome, they also bring their own problems. A first-of-its kind workshop in April, hosted by the Harvard School of Public Health and the Global Health Council, examined the organizational and ethical challenges of partnerships, and ways to address them.

引用

页码：617 / 620

页数：4

共 9 条

[1] Reich MR(2000)The global drug gap Science 287 1979- 1981
[2] Birmingham K(2000)The need for public–private partnerships Nature Med. 5 481-953
[3] Smith R(2000)Vaccines and medicines for the world's poorest: public-private partnerships seem to be essential Br. Med. J. 320 952 -S53
[4] Harrison PH(1999)A new model for collaboration: the alliance for microbicide development Intl. J. Gyn. & Ob. 67 S39-18
[5] Reich MR(1998)Dilemmas in drug development for tropical diseases: experiences with praziquantel Health Policy 44 1- 74
[6] Govindaraj R(1998)Partnerships for health in the 21st century World Health Stat. Q. 51 68-492
[7] Kickbusch I(2000)Ministers pledge to Stop TB Nature Med. 6 491-undefined
[8] Quick J(undefined)undefined undefined undefined undefined-undefined
[9] Birmingham K(undefined)undefined undefined undefined undefined-undefined

← 1 →